New · Paige Intelligence for PAAB

An AI compliance review
for every piece of
promotional content.

Paige reads your promotional pieces the way PAAB does — catching fair-balance issues, misleading charts, unsupported claims, and image context problems before your submission leaves the door.

Eleviora IVF medication advertisement depicting mother and baby
Paige Review
Critical · p.1 · imagery
CRITICAL PAAB Code 2.10
Authorized Use
The imagery depicts a mother holding a baby, which implies a successful pregnancy and live birth. This outcome is not guaranteed by the drug Eleviora™ (corifollitropin alfa), which is only authorized to support follicle development in IVF treatment. The depiction of a baby is a critical violation as it suggests an outcome that the drug cannot ensure.
RECOMMENDATION Ensure imagery depicts only populations, outcomes, and use contexts consistent with the authorized indication. Replace outcome imagery that exceeds the indication with imagery representing the actual authorized use. If patient imagery is retained, verify the depicted population matches the authorized patient selection criteria in the Product Monograph.

Most AI tools scan text.
Paige reads the whole page.

Paige reads your promotional piece the way a human reviewer does — recognizing when a 6-point footer is hiding what a 24-point headline is promising.

01
Reads the copy
Identifies claims, benefit-heavy language, and cross-references text structure against PAAB fair balance and data presentation standards.
02
Reads the layout
Analyzes typography hierarchy, spatial composition, font sizes, color contrast, and placement — detecting when safety information is cramped, low-contrast, or relegated to a footer.
03
Reads the imagery
Recognizes what photographs and visuals actually depict — flagging when imagery implies outcomes, patient populations, or use contexts beyond the authorized indication.
04
Reads the code
Maps findings to specific PAAB sections with severity, plain-language explanations, location pointers, and actionable recommendations.

Your content stays yours.

Papercurve has been purpose-built for life sciences since 2019. Data handling isn't an afterthought — it's the foundation.

No cross-client training
Your Paige instance learns from your team's reviews only. No client data is ever used to train models serving other customers.
Regional data residency
Data hosted in your region. Canada and US availability today, EU on the roadmap.
Human-in-the-loop, always
Paige surfaces findings for your reviewers to decide on. Final approval authority stays with your team — never with the AI.

Reviews that used to take weeks
now take days.

60%
Reduction in MLR review time across customer deployments.
10×
Faster reference linking with Paige auto-match.
77%
Improvement in document traceability (case study).

Grounded in the full PAAB code.

Paige Review evaluates your materials against the PAAB code of advertising acceptance. Here are a few of the sections it checks, with the kinds of violations it surfaces.

PAAB 2.4
Fair Balance of Risk and Benefit
A leading source of PAAB rejections. Detects imbalance between benefit messaging and risk communication across text, layout, and color contrast.
PAAB 4.2 · 4.3
Chart & Data Presentations
Flags truncated axes, disproportionate visual scaling, biased color choices, and other data presentations that distort the magnitude of clinical findings.
PAAB 2.10
Authorized Use
Reads photographs and visuals to flag when imagery implies outcomes, populations, or use contexts beyond the authorized indication.
PAAB 7.3
Product Monograph Disclosure
Verifies that required prescribing information and monograph references are present, properly positioned, and appropriately prominent throughout the piece.

Let's talk about how Paige fits
into your review workflow.

A 20-minute discovery call to understand your content pipeline, regulatory priorities, and where Paige can reduce review time. No prep required.